Development of a virtual Cyclin E1 biomarker for predicting overexpression in gynecological malignancy

Written By ViewsML

Partnership with Debiopharm with data presented at AACR 2026

Read the full poster here.

ViewsML
Previous

Mayo Clinic Backs Virtual Biomarker Startup $4.9M
Next

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform